Open AccessACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure
Author(s) -
A. I. Dyadyk,
A. E. Bagriy,
Игорь Григорьевич Лебедь,
N.F. Yarovaya,
E. V. Schukina,
Г. Г. Тарадин
Publication year - 1997
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/12.5.945
Subject(s) - medicine , enalapril , captopril , left ventricular hypertrophy , cardiology , blood pressure , heart failure , muscle hypertrophy , ace inhibitor , ventricle , kidney disease , renal function , angiotensin converting enzyme
Left ventricular hypertrophy is frequently noted in patients with moderate to severe chronic renal failure not requiring dialysis. Recently, several studies have shown reversal of myocardial hypertrophy in end-stage renal disease with long-term pharmacological control of blood pressure, but it is unclear whether left ventricular mass regresses or normalizes with antihypertensive treatment of patients with earlier stages of chronic renal failure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom